KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to $201.5 million.

  • Biomarin Pharmaceutical's Prepaid Assets rose 20.68% to $204.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.3 million, marking a year-over-year increase of 20.68%. This contributed to the annual value of $201.5 million for FY2024, which is 42.54% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Prepaid Assets stood at $201.5 million for FY2024, which was up 42.54% from $141.4 million recorded in FY2023.
  • In the past 5 years, Biomarin Pharmaceutical's Prepaid Assets registered a high of $201.5 million during FY2024, and its lowest value of $104.5 million during FY2022.
  • Over the past 3 years, Biomarin Pharmaceutical's median Prepaid Assets value was $141.4 million (recorded in 2023), while the average stood at $149.1 million.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Prepaid Assets fell by 15.00% in 2021 and then skyrocketed by 42.54% in 2024.
  • Yearly analysis of 5 years shows Biomarin Pharmaceutical's Prepaid Assets stood at $129.9 million in 2020, then dropped by 15.00% to $110.4 million in 2021, then dropped by 5.36% to $104.5 million in 2022, then spiked by 35.28% to $141.4 million in 2023, then spiked by 42.54% to $201.5 million in 2024.